Today: 23 March 2026
Subscribe
Browse Category

Stock Market 10 January 2026

Merck stock: $32 billion Revolution Medicines talks and vaccine-policy shift set up a busy week for MRK

Merck stock: $32 billion Revolution Medicines talks and vaccine-policy shift set up a busy week for MRK

Merck shares fell 0.4% to $110.53 Friday after reports it is in talks to acquire Revolution Medicines for $28–32 billion. Revolution shares jumped in after-hours trading. The Financial Times said negotiations are ongoing, with no final deal yet. Investors are watching Merck’s appearance at the J.P. Morgan Healthcare Conference on Jan. 12.
10 January 2026
··
Novo Nordisk Class B stock rises after Amazon adds Wegovy pill — what to watch before earnings

Novo Nordisk Class B stock rises after Amazon adds Wegovy pill — what to watch before earnings

Novo Nordisk shares rose 3% to 381.45 crowns in Copenhagen after Amazon Pharmacy began selling its new Wegovy weight-loss pill in the U.S. The pill, approved by the FDA in December, puts Novo ahead of Eli Lilly in the obesity pill market. About 8.95 million shares traded Friday, with prices ranging from 369.0 to 389.8 crowns. Novo will report full-year results on Feb. 4.
10 January 2026
··
AmEx (AXP) stock in focus after Trump calls for 10% cap on credit-card rates

AmEx (AXP) stock in focus after Trump calls for 10% cap on credit-card rates

American Express shares fell 1.9% Friday to $375.61 after President Donald Trump called for a one-year cap on credit card interest rates at 10%, starting Jan. 20. Trading volume in AmEx exceeded its 50-day average, while Capital One dropped 2.6%. Visa and Mastercard each slipped about 0.7% to 0.8%. AmEx will report fourth-quarter earnings on Jan. 30.
10 January 2026
·····
China Construction Bank Class A stock dips — inflation and Vanke debt talk keep lenders on edge

China Construction Bank Class A stock dips — inflation and Vanke debt talk keep lenders on edge

China Construction Bank’s Class A shares closed down 0.33% at 9.06 yuan in Shanghai Friday, trimming the weekly loss to about 2%. Trading volume reached 92.6 million shares. New inflation data showed December CPI up 0.8% year-on-year, while PPI fell 1.9%. Reports of China Vanke working on a debt restructuring plan renewed concerns over property sector risks for banks.
10 January 2026
···
Toyota stock pops after electric Hilux reveal; yen and tariff risk back in focus

Toyota stock pops after electric Hilux reveal; yen and tariff risk back in focus

Toyota’s U.S.-listed shares rose 3.2% to $221.52 Friday after unveiling a new Hilux lineup in Europe, including its first battery-electric model. The Hilux BEV, shown at the Brussels Motor Show, features a 59.2 kWh battery and 160-mile range, with sales set for April 2026. Toyota’s Tokyo shares closed up 2.85%. Investors are watching currency moves and upcoming Bank of Japan policy decisions.
10 January 2026
···
IBM stock in focus: new edge-AI rollout, CPI next week and Jan. 28 earnings ahead

IBM stock in focus: new edge-AI rollout, CPI next week and Jan. 28 earnings ahead

IBM shares closed Friday up 0.5% at $304.22 after trading between $301.14 and $306.90. Datavault AI said it will expand its partnership with IBM to launch an edge AI network in New York and Philadelphia using IBM’s watsonx. Investors await U.S. CPI data on Jan. 13 and IBM’s quarterly results on Jan. 28. IBM’s 52-week range is $214.50 to $324.90.
10 January 2026
···
Goldman Sachs stock near $939 as GS heads into Jan. 15 earnings and CPI week

Goldman Sachs stock near $939 as GS heads into Jan. 15 earnings and CPI week

Goldman Sachs shares closed Friday up 0.4% at $938.98, near early January highs, as Wall Street hit fresh records despite a mixed jobs report. The bank will release earnings around Jan. 15 via SEC Form 8-K. Goldman was tapped to advise on A.S. Watson’s potential $2 billion IPO and is vying for a role in Rio Tinto’s possible Glencore deal. Dividends on preferred stock are set for Feb. 10 and March.
10 January 2026
··
Caterpillar stock gains after CES AI assistant push; CPI and earnings are next test

Caterpillar stock gains after CES AI assistant push; CPI and earnings are next test

Caterpillar shares rose 1.6% to $617.62 Friday after the company showcased its new Cat AI Assistant and automation initiatives at CES in Las Vegas. The system, developed with Nvidia, is being piloted on excavators and aims to streamline equipment management. About 1.8 million shares traded. Investors now await Jan. 13 U.S. CPI data and upcoming Fed policy signals.
10 January 2026
···
SAP stock jumps on Wells Fargo “top platform” call as Jan 29 earnings near

SAP stock jumps on Wells Fargo “top platform” call as Jan 29 earnings near

SAP shares rose 2.8% in Frankfurt on Friday, closing at €212.35 after a Wells Fargo note named the company its top software platform pick for 2026. The stock outperformed the German market amid optimism over cloud and AI spending. Investors await U.S. inflation data on Jan. 13 and SAP’s earnings on Jan. 29. SAP’s ADRs climbed 2.6% in U.S. trading, ending at $247.11.
10 January 2026
··
Cisco (CSCO) stock in focus as Supreme Court takes up Falun Gong lawsuit appeal

Cisco (CSCO) stock in focus as Supreme Court takes up Falun Gong lawsuit appeal

Cisco Systems shares slipped 0.1% to $73.88 after the U.S. Supreme Court agreed to hear its appeal in a lawsuit alleging the company aided China’s surveillance of Falun Gong practitioners. The case centers on whether U.S. law allows “aiding and abetting” claims against corporations for overseas abuses. Cisco denies wrongdoing and welcomed the court’s review. The company will report quarterly earnings on Feb. 11.
10 January 2026
·····
AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next

AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next

Nasdaq said Friday that Walmart will replace AstraZeneca in the Nasdaq-100 before trading opens Jan. 20. AstraZeneca’s U.S. shares closed at $94.65, up 0.68%, with volume near 6.1 million. Investors are watching AstraZeneca’s management talks at the J.P. Morgan Healthcare Conference Jan. 12–14 and its full-year results on Feb. 10.
10 January 2026
···
1 … 558 559 560 561 562 … 1,359

Stock Market Today

  • Aflac (AFL) Shows Signs of Being Undervalued After Recent Price Drop
    March 22, 2026, 11:28 PM EDT. Aflac's stock price has fallen 6.8% over the past month, now trading around $106. Despite this pullback, the insurance company's share price remained flat over the last year. Analysts highlight a historical 80.4% return over three years and 131% over five years. Valuation checks rate Aflac 2 out of 6, but an Excess Returns analysis suggests the stock could be undervalued by about 40.9%, with an intrinsic value estimated at $179.78 per share. The return on equity of 14.09% exceeds its cost of equity, supporting potential upside. The current price-to-earnings ratio stands at 15.01, reflecting market views on growth and risk. Investors might consider reassessing Aflac as a buying opportunity amid recent price weakness.
Go toTop